Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception

Al Noman, M. A., Cuellar, R. A. D., Kyzer, J. L., Chung, S. S. W., Cheryala, N., Holth, T. A. D., Maitra, S., Naqvi, T., Wong, H. L., Schönbrunn, E., Hawkinson, J. E., Wolgemuth, D. J., & Georg, G. I. (2023). Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception. European Journal of Medicinal Chemistry, 261, 115821. https://doi.org/10.1016/j.ejmech.2023.115821
Authors:
Md Abdullah Al Noman
Rebecca A.D. Cuellar
Jillian L. Kyzer
Sanny S.W. Chung
Narsihmulu Cheryala
Trinh A.D. Holth
Soma Maitra
Tahmina Naqvi
Henry L. Wong
Ernst Schönbrunn
Jon E. Hawkinson
Debra J. Wolgemuth
Gunda I. Georg
Affiliated Authors:
Debra J. Wolgemuth
Subjects:
Testis (MeSH)
Contraception (MeSH)
Author Keywords:
male contraception
retinoic acid receptor alpha
selectivity
structure-activity relationships
Publication Type:
Article
Unique ID:
10.1016/j.ejmech.2023.115821
PMID:
Publication Date:
Data Source:
Scopus

Record Created: